Zomedica Pharmaceuticals's market cap is currently $118.18M. The company's EPS TTM is $-0.063; its P/E ratio is ―; Zomedica Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 25.19M	$ 18.93M	$ 4.13M	$ 0.00	$ 0.00
Gross Profit	$ 17.32M	$ 13.65M	$ 3.05M	$ -530.02K	$ -787.61K
Operating Income	$ -31.59M	$ -21.92M	$ -21.37M	$ -16.76M	$ -19.78M
EBITDA	$ -29.39M	$ -15.34M	$ -19.57M	$ -16.38M	$ -19.00M
Net Income	$ -34.53M	$ -17.02M	$ -18.38M	$ -16.92M	$ -19.82M
Balance Sheet
Cash & Short-Term Investments	$ 90.50M	$ 115.09M	$ 194.95M	$ 61.99M	$ 510.59K
Total Assets	$ 253.20M	$ 279.61M	$ 280.40M	$ 66.14M	$ 4.18M
Total Debt	$ 2.73M	$ 1.74M	$ 1.38M	$ 1.87M	$ 0.00
Net Debt	$ -10.22M	$ -25.66M	$ -193.57M	$ -60.12M	$ -510.59K
Total Liabilities	$ 13.18M	$ 12.22M	$ 9.51M	$ 15.08M	$ 2.09M
Stockholders' Equity	$ 240.02M	$ 267.39M	$ 270.89M	$ 51.07M	$ 2.10M
Cash Flow
Free Cash Flow	$ -20.62M	$ -12.70M	$ -14.80M	$ -16.26M	$ -16.32M
Operating Cash Flow	$ -15.97M	$ -11.67M	$ -14.28M	$ -16.24M	$ -15.63M
Investing Cash Flow	$ 1.58M	$ -155.88M	$ -71.93M	$ 1.01M	$ -686.93K
Financing Cash Flow	$ 0.00	$ 8.00K	$ 219.16M	$ 76.71M	$ 14.89M

Currency in USD

Zomedica Pharmaceuticals Earnings and Revenue History

Income Statement >

Zomedica Pharmaceuticals Debt to Assets

Balance Sheet >

Zomedica Pharmaceuticals Cash Flow

Cash Flow >

Zomedica Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing